Congress quietly funds maternal death prevention — but equity gaps remain

What it does

This bill reauthorizes and expands federal support for state maternal mortality review committees, which investigate pregnancy-related deaths to identify prevention opportunities. It requires the CDC to annually disseminate best practices on preventing maternal deaths to hospitals and quality-improvement organizations, and increases federal funding from $58 million to $100 million annually for fiscal years 2025–2029.

Why we flagged it

The bill extends and expands an existing federal maternal health surveillance and prevention program, increasing funding and clarifying committee composition and coordination requirements. It is a straightforward reauthorization with modest structural improvements.

What the text implies

• Explicit inclusion of obstetricians and gynecologists in committee membership may shift review focus toward clinical practice patterns and hospital protocols, potentially increasing scrutiny of provider decision-making in maternal deaths.
• New requirement for CDC to coordinate with 'death certifiers' and amend cause-of-death information on certificates may improve data quality for maternal mortality tracking but could create friction with state vital-statistics offices over authority to modify death records.
• Annual dissemination mandate to hospitals and quality collaboratives creates ongoing federal guidance on maternal mortality prevention, which may drive standardization of care protocols but could also face resistance from institutions with different clinical practices or resource constraints.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Pregnant people and families benefit from expanded maternal mortality review capacity, improved death investigation and record-keeping, and systematic dissemination of evidence-based prevention practices. The bill increases federal investment in infrastructure designed to reduce preventable pregnancy-related deaths and improve care quality.

Who stands to gain

• State health departments (maternal mortality review committee funding)
• CDC and HRSA (expanded program administration)
• Hospitals and perinatal quality collaboratives (recipients of best-practice guidance and potential q

Named in the bill

Centers for Disease Control and Prevention (CDC), Health Resources and Services Administration (HRSA), Public Health Service Act Section 317K, State maternal mortality review committees, Hospitals, State professional society groups, Perinatal quality collaboratives

Where it stands

24 cosponsors: 20 Democrats, 4 Republicans.

• Mar 6, 2025 — Introduced · Congress.gov: “Introduced in House”
• Mar 6, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

13 lobbying clients named this bill on 16 disclosure filings across 3 quarters, Dec 2025 to Jun 2026. Those filings disclosed $2,098,016 in lobbying spend. A filing names 18 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 94% of bills with at least one filing.

Buddy Carter, the sponsor, reported $988,325 in PAC receipts in the 2026 cycle.

• American Psychiatric Association — $529,365 on 2 filings
• American Federation of Teachers — $410,000 on 1 filing
• American Academy of Pediatrics — $320,000 on 1 filing
• Catholic Health Association of the United States — $240,651 on 1 filing
• American College of Obstetricians and Gynecologists — $230,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.